Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Payables (2016 - 2025)

Historic Payables for Tandem Diabetes Care (TNDM) over the last 14 years, with Q3 2025 value amounting to $47.5 million.

  • Tandem Diabetes Care's Payables fell 261.11% to $47.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $47.5 million, marking a year-over-year decrease of 261.11%. This contributed to the annual value of $44.7 million for FY2024, which is 979.31% down from last year.
  • According to the latest figures from Q3 2025, Tandem Diabetes Care's Payables is $47.5 million, which was down 261.11% from $55.8 million recorded in Q2 2025.
  • Tandem Diabetes Care's 5-year Payables high stood at $61.5 million for Q3 2022, and its period low was $27.0 million during Q3 2021.
  • For the 5-year period, Tandem Diabetes Care's Payables averaged around $46.6 million, with its median value being $48.1 million (2024).
  • Its Payables has fluctuated over the past 5 years, first skyrocketed by 12812.07% in 2022, then tumbled by 2501.02% in 2023.
  • Quarter analysis of 5 years shows Tandem Diabetes Care's Payables stood at $28.0 million in 2021, then surged by 98.81% to $55.7 million in 2022, then fell by 11.02% to $49.6 million in 2023, then dropped by 9.79% to $44.7 million in 2024, then rose by 6.15% to $47.5 million in 2025.
  • Its Payables was $47.5 million in Q3 2025, compared to $55.8 million in Q2 2025 and $59.8 million in Q1 2025.